ORTHOGEN is a biotech company developing autologous therapy for orthopaedic injuries and diseases. The therapy involves extracting anti-inflammatory and pain-inhibiting proteins from a patient’s blood and injecting them into an affected joint. These substances stop inflammation of joints and nerve roots, regenerate joint cartilage, and accelerate healing of fractures.